John Humphrey AMUASI is based at the Kwame Nkrumah University of Science and Technology (KNUST), where he is Head of the Global Health Department of the School of Public Health and Leader of the Global One Health Research Group at the Kumasi Center for Collaborative Research in Tropical Medicine (KCCR). Amuasi is also a W2 Professor of Global One Health at the Bernhard Nocht Institute of Tropical Medicine and the University of Eppendorf in Hamburg, Germany, an adjunct Professor at the University of Minnesota School of Public Health in the USA, and an Honorary Visiting Research Fellow in Tropical Medicine at the University of Oxford in the UK. Amuasi trained as a physician in Ghana, and later graduated from the University of Minnesota School of Public Health, USA, with post-graduate degrees terminating in a PhD in Health Research and Policy. Amuasi set up and was the inaugural head of the Research and Development Unit at the 1,200-bed Komfo Anokye teaching Hospital in Kumasi. For over 20 years, he has engaged in Tropical Medicine and Global Health research in LMICs – including in malaria, NTDs, AMR and One Health. He has also consulted for several Global Health-focused organizations and supported civil society organizations with technical expertise on matters related to access to drugs, vaccines, and diagnostics, as well as strategic advice related to Global Health research priorities. Amuasi’s current research involves clinical and field epidemiologic studies on malaria, emerging and re-emerging infectious diseases, AMR, snakebite and other neglected tropical diseases. He currently serves as an Executive Committee member of the EDCTP2-funded African Coalition for Epidemic Research, Response and Training (ALERRT), where he leads the operational readiness and resilience work package of the Network. Through ALERRT at KCCR, he is coordinating research on the clinical characterization of COVID-19 in Senegal, Guinea, Ghana, Cameroon, Uganda, Kenya and the DRC. Amuasi also serves as PI for a number of other studies on COVID-19 in Ghana, including some phase III clinical trials for drugs and vaccines involving both consortia and pharma. He further serves as Co-Chair of The Lancet One Health Commission, an adjunct to a number of academic institutions, and as a regular technical advisor/contributor to the WHO, Africa CDC, African Academy of Sciences, and several other Global Health organizations. Amuasi is passionate about mentorship and sustainably building both clinical and non-clinical health research capacities in Africa.